GO-PEG as a drug nanocarrier and its antiproliferative effect on human cervical cancer cell line

Artif Cells Nanomed Biotechnol. 2017 May;45(3):568-573. doi: 10.3109/21691401.2016.1161641. Epub 2016 Mar 30.

Abstract

The graphene oxide nanosheets can act as a nanocarrier for the delivery of therapeutic agents. The PEGylated GO has high solubility, good stability, and more biocompatibility in physiological solutions. In this study, the anticancer effects of synthesized GO-PEG as a drug nanocarrier evaluated to estimate the synergistic cytotoxic effect of drugs loaded on this type of nanocarrier and to determine the actual effect of any drugs encapsulated on it. The cytotoxic effects of GO-PEG nanosheets were evaluated on HeLa cell line by MTT assay. The results exhibited cytotoxic property of PEGylated GO drug nanocarrier significantly is dose dependent and incubation time dependent.

Keywords: Anticancer; MTT assay; PEGylated; graphene oxide; nanocarrier.

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Biological Transport
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Drug Carriers*
  • Drug Liberation
  • Graphite / chemistry
  • Graphite / pharmacology*
  • HeLa Cells
  • Humans
  • Kinetics
  • Nanoparticles / chemistry*
  • Nanoparticles / ultrastructure
  • Oxides
  • Particle Size
  • Polyethylene Glycols / chemistry*
  • Solubility

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Oxides
  • Polyethylene Glycols
  • Graphite